Product Information
COSENTYX UNOREADY 300 MG/2 ML PEN (1 PEN) is a brand product labeled by Novartis Pharmaceuticals Corporation, priced at $4088.1014 per ML under NDC 00078107068. Its NADAC has been published 114 times since Jun 19, 2024.
Strength
300 mg/2mL
Manufacturer
Novartis Pharmaceuticals CorporationNDC
00078107068
Classification
Brand
Dosage Form
INJECTION
Route
SUBCUTANEOUS
Effective Date
8/19/2026
Active Ingredients
SECUKINUMABApproval Type
Biologic (BLA)
FDA Application
BLA125504On Market Since
1/21/2015
Pharmacological Classes
Price Statistics
The NADAC for COSENTYX UNOREADY 300 MG/2 ML PEN (1 PEN) has been published 114 times since Jun 19, 2024, and over the history we have for it it has risen 13.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4088.1014 per ML |
|---|---|
| All-time high | $4105.5041 (May 13, 2026) |
| All-time low | $3591.8962 (Sep 18, 2024) |
| 52-week high | $4105.5041 |
| 52-week low | $3836.9198 |
| Median price | $3836.9198 |
| Average price | $3819.9407 |
| Largest weekly change | +7.0% (Jan 14, 2026) |
| Weeks tracked | 114 |
| Tracking since | Jun 19, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the secukinumab market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of COSENTYX UNOREADY 300 MG/2 ML PEN (1 PEN)?
The current National Average Drug Acquisition Cost (NADAC) for COSENTYX UNOREADY 300 MG/2 ML PEN (1 PEN), manufactured by Novartis Pharmaceuticals Corporation, is $4088.1014 per ML (NDC 00078107068), effective Aug 19, 2026.
How has the price of COSENTYX UNOREADY 300 MG/2 ML PEN (1 PEN) changed over time?
Over the history we have for it, the NADAC for COSENTYX UNOREADY 300 MG/2 ML PEN (1 PEN) has risen 13.2%. It has been tracked across 114 weekly CMS publications since Jun 19, 2024.
What are the highest and lowest recorded NADAC prices for COSENTYX UNOREADY 300 MG/2 ML PEN (1 PEN)?
Since Jun 19, 2024, the NADAC for COSENTYX UNOREADY 300 MG/2 ML PEN (1 PEN) has ranged from a low of $3591.8962 (Sep 18, 2024) to a high of $4105.5041 (May 13, 2026), with a median of $3836.9198 per ML.
Are there cheaper alternatives to COSENTYX UNOREADY 300 MG/2 ML PEN (1 PEN)?
No other NADAC-published product currently shares the active ingredient and strength of COSENTYX UNOREADY 300 MG/2 ML PEN (1 PEN) in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures COSENTYX UNOREADY 300 MG/2 ML PEN (1 PEN)?
COSENTYX UNOREADY 300 MG/2 ML PEN (1 PEN) (NDC 00078107068) is labeled by Novartis Pharmaceuticals Corporation, and CMS classifies it as a brand product.